| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 185 |
| 1 | OLAPARIB | 142 |
| 2 | CARBOPLATIN | 133 |
| 3 | RUCAPARIB | 119 |
| 4 | PACLITAXEL | 87 |
| 5 | BEVACIZUMAB | 80 |
| 6 | GEMCITABINE HYDROCHLORIDE | 49 |
| 7 | GEMCITABINE | 42 |
| 8 | CISPLATIN | 38 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0263 |
| 1 | RUCAPARIB | 119 | 0.0158 |
| 2 | OLAPARIB | 142 | 0.0147 |
| 3 | NIRAPARIB | 185 | 0.0126 |
| 4 | CHERYLEE MD SENSITIVE SKIN CARE TRUELIPIDS DOUBLE ACTION BOO-BOO BUM | 3 | 0.0075 |
| 5 | PANTHENOL | 1 | 0.0048 |
| 6 | WHITE PETROLATUM | 3 | 0.0041 |
| 7 | TOPOTECAN | 20 | 0.0041 |
| 8 | POVIDONE IODINE 10% | 2 | 0.0037 |
| 9 | GLYCERINE | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 321 |
| 1 | Platinum-based Drug [EPC] | 144 |
| 2 | Microtubule Inhibitor [EPC] | 98 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 80 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 42 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 6 | Topoisomerase Inhibitor [EPC] | 27 |
| 7 | Alkylating Drug [EPC] | 22 |
| 8 | Aromatase Inhibitor [EPC] | 22 |
| 9 | Corticosteroid [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 321 | 0.0132 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0011 |
| 2 | Melatonin Receptor Agonist [EPC] | 10 | 0.0009 |
| 3 | Microtubule Inhibitor [EPC] | 98 | 0.0009 |
| 4 | Platinum-based Drug [EPC] | 144 | 0.0008 |
| 5 | Antiseptic [EPC] | 2 | 0.0006 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 80 | 0.0006 |
| 7 | Topoisomerase Inhibitor [EPC] | 27 | 0.0005 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 9 | Phenothiazine [EPC] | 6 | 0.0003 |